Please assess the completion status of the following clinical trial:

Trial Title: Blood Flow Restriction Following ACL Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 13-35 years at the time of surgery~2. Anterior Cruciate Ligament (ACL) reconstruction~3. Using a physical therapy center with Blood Flow Restriction capabilities.~Exclusion Criteria:~1. Concomitant ligament reconstruction~2. Concurrent procedures that require delayed weight bearing (ie: High Tibial Osteotomy (HTO), multi-ligament reconstruction, microfracture, etc)~3. History of Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE)~4. Immunocompromising conditions (ie: Rheumatoid arthritis, chronic steroid use, etc.)~5. History of coagulation disorders or current use of anticoagulants~6. Completion of physical therapy at a location not affiliated with the study~7. Pregnancy

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- BFR Therapy (Type: EXPERIMENTAL): This group will undergo physical therapy exercises per the standard of care, with the addition of Blood Flow Restriction (BFR) utilizing a wide pressure cuff. BFR exercises will be initiated two weeks post-op, and continued for 16 weeks.
- No BFR (Type: ACTIVE_COMPARATOR): This group of patients will undergo physical therapy exercises per the current standard of care after their ACL reconstruction without BFR

Based on this trial design, predict the completion outcome and termination type (if applicable).